Literature DB >> 15331062

Nonalcoholic fatty liver disease in individuals with severe obesity.

Paul Haynes1, Suthat Liangpunsakul, Naga Chalasani.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disorder occurring in individuals without significant alcohol consumption. It consists of a spectrum of liver disease, ranging from simple steatosis to steatohepatitis, cirrhosis, liver failure, and hepatocellular carcinoma. Although a number of conditions have been identified as risk factors, obesity is by far the most dominant risk factor for developing NAFLD. Over the past decade, it became apparent that NAFLD in some patients is a progressive disorder,leading to cirrhosis and liver failure. Despite lack of direct evidence,due to the ongoing epidemic of obesity in western countries, it is believed that the incidence of NAFLD is increasing, and patients with complicated and uncomplicated NAFLD will present in increasing numbers to primary care physicians as well as specialists. This article discusses the prevalence, histologic spectrum, and natural history of NAFLD in subjects with severe obesity as well as the hepatic effects of drastic weight loss induced by bariatric surgery or severe calorie restriction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331062     DOI: 10.1016/j.cld.2004.04.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  21 in total

1.  Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Seyed Rafie Arefhosseini; Mehrangiz Ebrahimi-Mameghani; Alireza Farsad Naeimi; Manoochehr Khoshbaten; Javad Rashid
Journal:  Health Promot Perspect       Date:  2011-12-20

Review 2.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

3.  Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.

Authors:  Samer G Mattar; Laura M Velcu; Mordechai Rabinovitz; A J Demetris; A M Krasinskas; Emma Barinas-Mitchell; George M Eid; Ramesh Ramanathan; Debra S Taylor; Philip R Schauer
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

4.  Choline intake in a large cohort of patients with nonalcoholic fatty liver disease.

Authors:  Anthony L Guerrerio; Ryan M Colvin; Amy K Schwartz; Jean P Molleston; Karen F Murray; AnnaMae Diehl; Parvathi Mohan; Jeffrey B Schwimmer; Joel E Lavine; Michael S Torbenson; Ann O Scheimann
Journal:  Am J Clin Nutr       Date:  2012-02-15       Impact factor: 7.045

Review 5.  Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery.

Authors:  Steven H Belle; Paul D Berk; Anita P Courcoulas; David R Flum; Carolyn W Miles; James E Mitchell; Walter J Pories; Bruce M Wolfe; Susan Z Yanovski
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

6.  Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

Authors:  Dima L Diab; Lisa Yerian; Philip Schauer; Sangeeta R Kashyap; Rocio Lopez; Stanley L Hazen; Ariel E Feldstein
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-26       Impact factor: 11.382

7.  Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding.

Authors:  Amalia Gastaldelli; Lucia Perego; Michele Paganelli; Giorgio Sesti; Marta Hribal; Alberto O Chavez; Ralph A Defronzo; Antonio Pontiroli; Franco Folli
Journal:  Obes Surg       Date:  2008-09-24       Impact factor: 4.129

8.  Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients.

Authors:  Víctor Vargas; Helena Allende; Albert Lecube; Maria Teresa Salcedo; Juan A Baena-Fustegueras; José M Fort; Joaquín Rivero; Roser Ferrer; Roberto Catalán; Eva Pardina; Santiago Ramón Y Cajal; Jaime Guardia; Julia Peinado-Onsurbe
Journal:  World J Hepatol       Date:  2012-12-27

Review 9.  Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance.

Authors:  Paul D Berk; Elizabeth C Verna
Journal:  Clin Liver Dis       Date:  2016-02-18       Impact factor: 6.126

10.  Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Authors:  Brent A Neuschwander-Tetri; David A Ford; Sahaja Acharya; George Gilkey; Metin Basaranoglu; Laura H Tetri; Elizabeth M Brunt
Journal:  Lipids       Date:  2012-08-26       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.